- Home
- ASMB vs PHUN Comparison
ASMB vs PHUN Comparison
Compare ASMB & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- PHUN
- Stock Information
- Founded
- ASMB 2005
- PHUN 2009
- Country
- ASMB United States
- PHUN United States
- Employees
- ASMB N/A
- PHUN N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- PHUN EDP Services
- Sector
- ASMB Health Care
- PHUN Technology
- Exchange
- ASMB Nasdaq
- PHUN Nasdaq
- Market Cap
- ASMB 138.4M
- PHUN 64.1M
- IPO Year
- ASMB 2010
- PHUN N/A
- Fundamental
- Price
- ASMB $18.09
- PHUN $3.52
- Analyst Decision
- ASMB Strong Buy
- PHUN Buy
- Analyst Count
- ASMB 3
- PHUN 2
- Target Price
- ASMB $33.00
- PHUN $7.75
- AVG Volume (30 Days)
- ASMB 44.2K
- PHUN 346.3K
- Earning Date
- ASMB 08-07-2025
- PHUN 08-07-2025
- Dividend Yield
- ASMB N/A
- PHUN N/A
- EPS Growth
- ASMB N/A
- PHUN N/A
- EPS
- ASMB N/A
- PHUN N/A
- Revenue
- ASMB $32,154,000.00
- PHUN $2,956,000.00
- Revenue This Year
- ASMB $0.04
- PHUN $3.01
- Revenue Next Year
- ASMB N/A
- PHUN $50.72
- P/E Ratio
- ASMB N/A
- PHUN N/A
- Revenue Growth
- ASMB 148.33
- PHUN N/A
- 52 Week Low
- ASMB $7.75
- PHUN $2.22
- 52 Week High
- ASMB $19.93
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- ASMB 64.35
- PHUN 60.52
- Support Level
- ASMB $17.76
- PHUN $3.25
- Resistance Level
- ASMB $18.99
- PHUN $3.10
- Average True Range (ATR)
- ASMB 0.80
- PHUN 0.17
- MACD
- ASMB -0.08
- PHUN 0.04
- Stochastic Oscillator
- ASMB 63.86
- PHUN 94.37
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.